Sandoz Gefitinib 250 mg

Sandoz Gefitinib 250 mg tablets are a prescription medication used to treat certain types of cancer. This oral treatment is designed to target specific proteins in cancer cells, helping to slow their growth.

Gefitinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or recurred. It works by targeting specific proteins involved in cancer cell growth, making it a targeted therapy. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its ability to interfere with the growth and spread of cancer cells.

Common effects of Gefitinib may include skin rash, diarrhea, and nausea. Some patients may also experience appetite loss or fatigue. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Gefitinib should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or those taking other medications should discuss this with their healthcare provider before starting Gefitinib.

Gefitinib may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, smoking can affect the effectiveness of Gefitinib.